SEC Filings TLDR

This filing is Amendment No. 8 to Schedule 13D for Adicet Bio, Inc., submitted by OrbiMed Advisors LLC and related entities. The amendment reflects changes in the ownership percentage of the Reporting Persons due to an increase in the number of outstanding shares following a registered direct offering of 70,001,000 sha...

This Amendment No. 9 to Schedule 13D, filed by Jack Jiajia Huang and related entities, updates the ownership details of Class A ordinary shares of 51Talk Online Education Group. The filing discloses significant open-market purchases of ADSs by Dasheng Global Limited and HH Talent Limited, totaling approximately US$10.7...

This Amendment No. 1 to Schedule 13D, filed by Leon O. Moulder, Jr., Tellus BioVentures, LLC, and Leon O. Moulder, Jr. Revocable Trust, provides updates on their ownership and transactions involving Zenas BioPharma, Inc. The amendment highlights the purchase of 36,928 shares of Common Stock by the Trust at $20.85 per s...

HealthCap VIII, L.P. has filed an amendment to its Schedule 13D, indicating a reduction in its ownership stake in Spruce Biosciences, Inc. On October 7, 2025, HealthCap VIII, L.P. sold 12,500 shares of Common Stock at $205.99 per share. As of October 9, 2025, HealthCap VIII, L.P. and its related entities ceased to be b...

This filing, Amendment No. 8 to Schedule 13D, pertains to Redwire Corp and is submitted by Bain Capital Credit Member, LLC and BCCR. The amendment serves as an exit filing for the Reporting Persons, as they no longer own more than five percent of the Common Stock of Redwire Corp. The filing details the conversion of 28...

This Amendment No. 5 to Schedule 13D/A, filed by Fluor Corporation, Fluor Enterprises, Inc., and NuScale Holdings Corp., updates the ownership details of Class A Common Stock of NuScale Power Corporation. The amendment reflects the sale of 15,000,000 shares of Class A Common Stock by Fluor Enterprises, completed on Oct...

This filing is Amendment No. 11 to the Schedule 13D for Insight Enterprises, Inc., submitted by ValueAct Capital and related entities. The amendment updates the beneficial ownership of the reporting persons, who collectively own approximately 6.7% of the issuer's outstanding common stock. The filing includes details of...

Great Elm Group, Inc. filed Amendment No. 14 to its Schedule 13D regarding its beneficial ownership of Great Elm Capital Corp. common stock. The amendment reports that the Reporting Person granted 79,803 shares of Common Stock as compensation to certain employees between September 19, 2025, and September 23, 2025. As o...

This filing, Amendment No. 14 to the Schedule 13D for Great Elm Capital Corp., updates the beneficial ownership information of the reporting person, Great Elm Group, Inc. The amendment details the grant of 79,803 shares of Common Stock to certain employees as compensation, with no consideration received. The reporting ...

This Amendment No. 5 to Schedule 13D, filed by Novo Holdings A/S, updates the ownership details of Galecto, Inc.'s Common Stock. Novo Holdings A/S, a Danish corporation wholly owned by the Novo Nordisk Foundation, reported that it ceased to be a beneficial owner of more than five percent of the Common Stock on October ...

This Amendment No. 5 to Schedule 13D/A, filed by Fluor Corporation, Fluor Enterprises, Inc., and NuScale Holdings Corp., updates the ownership details of Class A Common Stock of NuScale Power Corporation. The amendment discloses that Fluor Enterprises completed the sale of 15,000,000 shares of Class A Common Stock on O...

This Amendment No. 4 to the Schedule 13D for eGain Corp, filed on October 9, 2025, updates the transactions in securities as previously reported. The filing details the beneficial ownership of shares by Philotimo Fund, LP, Philotimo Focused Growth & Income Fund, Kanen Wealth Management LLC, and David L. Kanen. The aggr...

Two Seas Capital LP, along with Two Seas Capital GP LLC and Sina Toussi, filed Amendment No. 1 to their Schedule 13D regarding their holdings in Core Scientific, Inc. The amendment updates the aggregate purchase prices of shares held by the Strategic Fund, Global Fund, and Accounts, totaling approximately $180,431,649....

Taiwan Carbon Nano Technology Corporation (TCNT) filed an amendment to its Schedule 13D regarding its holdings in Ainos, Inc. TCNT holds 1,037,206 shares of Ainos' common stock, representing 21.79% of the outstanding shares. The shares were acquired through a license agreement where TCNT granted Ainos exclusive rights ...

Ainos, Inc. filed Amendment No. 12 to Schedule 13D, disclosing changes in ownership and transactions involving its common stock. The amendment includes details of a one-for-five reverse stock split effected on June 30, 2025, and the sale of 62,794 shares of common stock by Taiwan Carbon Nano Technology Corporation (TCN...

This Amendment No. 10 to the Schedule 13D for lululemon athletica inc. is filed by Dennis J. Wilson and other reporting persons to update Item 4 and Item 7 of the Schedule 13D. The amendment reflects statements made by Mr. Wilson in The Wall Street Journal on October 7, 2025, regarding his views on the Issuer, its mana...

This Amendment No. 5 to Schedule 13D, filed by Reprogrammed Interchange LLC and Reid Hoffman, updates the previously filed Schedule 13D and its amendments. The filing reports significant changes in the ownership of Vor Biopharma Inc.'s common stock. Specifically, Reprogrammed Interchange LLC sold 70,763 shares on Octob...

Fund 1 Investments, LLC has filed an amendment to its Schedule 13D for TILLY'S, INC., reporting beneficial ownership of 8,058,268 shares of Class A Common Stock, representing approximately 34.8% of the outstanding shares. The shares were purchased with working capital of the Funds, including potential margin loans. On ...

This Amendment No. 3 to Schedule 13D, filed on October 8, 2025, pertains to the common stock of OPENLANE, Inc. (formerly KAR Auction Services, Inc.). The amendment reports a significant transaction where OPENLANE, Inc. entered into a Repurchase Agreement with Ignition Acquisition Holdings LP on September 9, 2025. Under...

This Amendment No. 1 to the Schedule 13D, filed by Diveroli Investment Group LLC and Kingbird Ventures LLC (the "Reporting Persons"), amends and restates the original Schedule 13D filed on July 18, 2025. The Reporting Persons own 737,000 shares of common stock of LQR House Inc., representing approximately 7.1% of the o...

This Amendment No. 1 to Schedule 13D, filed by Fairmount Funds Management LLC and related entities, updates the ownership and transaction details regarding the Common Stock of Jade Biosciences, Inc. The amendment highlights that the Reporting Persons now have voting and dispositive power over 10,353,875 shares of Commo...

This filing represents Amendment No. 4 to the Schedule 13D for eGain Corp, submitted by Philotimo Fund, LP, Philotimo Focused Growth & Income Fund, Kanen Wealth Management LLC, and David L. Kanen. The amendment updates the beneficial ownership of eGain Corp's common stock. As of October 8, 2025, Philotimo Fund, LP bene...

This filing, Amendment No. 17 to Schedule 13D, pertains to CF Bankshares Inc. and was submitted by Castle Creek Capital Partners VII, LP. The amendment updates the ownership details of the company's common stock. Between September 23, 2025, and October 6, 2025, Castle Creek Capital Partners VII, LP sold 70,621 shares o...

This Amendment No. 2 to Schedule 13D, filed by Valor BrainsWay Holdings, LLC and other reporting persons, updates the ownership details of Brainsway Ltd. The amendment highlights the exercise of a warrant by Valor BrainsWay, resulting in the issuance of 553,730 American Depository Shares (ADSs) representing 1,107,460 O...

American Ventures LLC, Series XVI AGH, along with its affiliates and related individuals, filed an amended Schedule 13D with the SEC regarding their holdings in Aureus Greenway Holdings Inc. The filing discloses that Series XVI AGH directly owns 59,654 shares of common stock and has the right to acquire additional shar...